[
  {
    "ts": "2026-02-03T01:38:48+00:00",
    "headline": "Becton, Dickinson and Company (BDX): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Becton, Dickinson and Company on Value Don’t Lie’s Substack. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company’s share was trading at $201.09 as of January 29th. BDX’s trailing and forward P/E were 34.55 and 13.44 respectively according to Yahoo Finance. Becton, Dickinson and Company develops, manufactures, […]",
    "url": "https://finance.yahoo.com/news/becton-dickinson-company-bdx-bull-013848490.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8be2b1e4-9486-3fba-8162-39b8b94d1d51",
      "content": {
        "id": "8be2b1e4-9486-3fba-8162-39b8b94d1d51",
        "contentType": "STORY",
        "title": "Becton, Dickinson and Company (BDX): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Becton, Dickinson and Company on Value Don’t Lie’s Substack. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company’s share was trading at $201.09 as of January 29th. BDX’s trailing and forward P/E were 34.55 and 13.44 respectively according to Yahoo Finance. Becton, Dickinson and Company develops, manufactures, […]",
        "pubDate": "2026-02-03T01:38:48Z",
        "displayTime": "2026-02-03T01:38:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3370590db737e59fb2f15f745fd120ab",
          "originalWidth": 750,
          "originalHeight": 500,
          "caption": "Astera Labs (ALAB) Declines 13% on Profit-Taking",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/newMfNg65Vf0NI6jIp7tWw--~B/aD01MDA7dz03NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3370590db737e59fb2f15f745fd120ab.cf.webp",
              "width": 750,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGkLyRaQb6WBPU_S77FLmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3370590db737e59fb2f15f745fd120ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/becton-dickinson-company-bdx-bull-013848490.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/becton-dickinson-company-bdx-bull-013848490.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            },
            {
              "symbol": "WAT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T13:34:04+00:00",
    "headline": "Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX)",
    "summary": "Becton, Dickinson and Company (NYSE:BDX) is included among the Dividend Growth Stocks: 25 Aristocrats. On January 28, Piper Sandler analyst Jason Bednar lifted Becton, Dickinson and Company (NYSE:BDX)’s price recommendation to $205 from $190. The analyst maintained a Neutral rating. The firm pointed to changes in how BD reports its business units starting in Q1 […]",
    "url": "https://finance.yahoo.com/news/piper-sandler-highlights-upcoming-segment-133404709.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5ff2285a-ebf1-3afa-b0d7-49f98e8eace8",
      "content": {
        "id": "5ff2285a-ebf1-3afa-b0d7-49f98e8eace8",
        "contentType": "STORY",
        "title": "Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX)",
        "description": "",
        "summary": "Becton, Dickinson and Company (NYSE:BDX) is included among the Dividend Growth Stocks: 25 Aristocrats. On January 28, Piper Sandler analyst Jason Bednar lifted Becton, Dickinson and Company (NYSE:BDX)’s price recommendation to $205 from $190. The analyst maintained a Neutral rating. The firm pointed to changes in how BD reports its business units starting in Q1 […]",
        "pubDate": "2026-02-03T13:34:04Z",
        "displayTime": "2026-02-03T13:34:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/c5231be68f8a8ee09937b7b67ae3b30f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SLHA.Vdeuq8l9LZkY.KPHw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c5231be68f8a8ee09937b7b67ae3b30f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZMhN4As..J8nLEyf5T6SwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/c5231be68f8a8ee09937b7b67ae3b30f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/piper-sandler-highlights-upcoming-segment-133404709.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/piper-sandler-highlights-upcoming-segment-133404709.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T15:00:10+00:00",
    "headline": "Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth",
    "summary": "Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finance.yahoo.com/news/staar-surgical-staa-report-q4-150010536.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6238c960-bfd6-3a4b-893c-4378df51f53b",
      "content": {
        "id": "6238c960-bfd6-3a4b-893c-4378df51f53b",
        "contentType": "STORY",
        "title": "Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth",
        "description": "",
        "summary": "Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
        "pubDate": "2026-02-03T15:00:10Z",
        "displayTime": "2026-02-03T15:00:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E8QyPjKtRaOQj91uVCJHQA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hjTg63kWHBfUb8JQmmr1kg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/staar-surgical-staa-report-q4-150010536.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/staar-surgical-staa-report-q4-150010536.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "STAA"
            },
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]